2019 Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Carré M Journal Biol Blood Marrow Transplant.
2019 A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cremers EMP Journal Leuk Lymphoma.
2019 Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Group Chronic Malignancies Working Party (CMWP) Lymphoma Working Party (LWP) Other society 1st listed author Michallet M Journal Bone Marrow Transplant.
2019 An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Hayden PJ Journal Curr Res Transl Med.
2019 Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gagelmann N Journal Haematologica.
2019 Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Br J Haematol.
2018 Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia. Group Chronic Malignancies Working Party (CMWP) 1st listed author Schetelig J Journal Leukemia.
2018 Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion. Group Chronic Malignancies Working Party (CMWP) 1st listed author Garderet L Journal Biol Blood Marrow Transplant.
2018 High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapies. Group Chronic Malignancies Working Party (CMWP) Other society 1st listed author Dreger P Journal Blood.
2018 Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author van Gorkom G Journal Bone Marrow Transplant.
2018 Family mismatched allogeneic stem cell transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Raj K Journal Biol Blood Marrow Transplant.
2018 Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author McLornan DP Journal Br J Haematol.